Search Results - "Pirollo, Kathleen"

Refine Results
  1. 1

    Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide by Kim, Sang-Soo, Harford, Joe B, Moghe, Manish, Rait, Antonina, Pirollo, Kathleen F, Chang, Esther H

    Published in Nucleic acids research (16-02-2018)
    “…Abstract Intrinsic therapeutic resistance especially in cancer stem cells (CSCs) together with extensive tumor cell infiltration and restricted permeation of…”
    Get full text
    Journal Article
  2. 2

    Effective treatment of glioblastoma requires crossing the blood–brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine by Kim, Sang-Soo, Harford, Joe B., Pirollo, Kathleen F., Chang, Esther H.

    “…Glioblastoma multiforme (GBM) is the most aggressive and lethal type of brain tumor. Both therapeutic resistance and restricted permeation of drugs across the…”
    Get full text
    Journal Article
  3. 3

    Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors by Senzer, Neil, Nemunaitis, John, Nemunaitis, Derek, Bedell, Cynthia, Edelman, Gerald, Barve, Minal, Nunan, Robert, Pirollo, Kathleen F, Rait, Antonina, Chang, Esther H

    Published in Molecular therapy (01-05-2013)
    “…Selective delivery of therapeutic molecules to primary and metastatic tumors is optimal for effective cancer therapy. A liposomal nanodelivery complex (scL)…”
    Get full text
    Journal Article
  4. 4

    Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study by Pirollo, Kathleen F, Nemunaitis, John, Leung, Po Ki, Nunan, Robert, Adams, Jana, Chang, Esther H

    Published in Molecular therapy (01-09-2016)
    “…Loss of p53 suppressor function, through mutations or inactivation of the p53 pathway, occurs in most human cancers. SGT-53 is a liposomal nanocomplex designed…”
    Get full text
    Journal Article
  5. 5

    Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma by Kim, Sang-Soo, Rait, Antonina, Kim, Eric, DeMarco, James, Pirollo, Kathleen F, Chang, Esther H

    Published in Cancer letters (01-12-2015)
    “…Highlights • GBM is the most aggressive and lethal type of brain tumor with a poor prognosis. • Novel strategies are needed to improve limited efficacy of TMZ…”
    Get full text
    Journal Article
  6. 6

    A Nanoparticle Carrying the p53 Gene Targets Tumors Including Cancer Stem Cells, Sensitizes Glioblastoma to Chemotherapy and Improves Survival by Kim, Sang-Soo, Rait, Antonina, Kim, Eric, Pirollo, Kathleen F, Nishida, Maki, Farkas, Natalia, Dagata, John A, Chang, Esther H

    Published in ACS nano (24-06-2014)
    “…Temozolomide (TMZ)-resistance in glioblastoma multiforme (GBM) has been linked to upregulation of O 6-methylguanine-DNA methyltransferase (MGMT). Wild-type…”
    Get full text
    Journal Article
  7. 7
  8. 8

    TP53 Gene Therapy as a Potential Treatment for Patients with COVID-19 by Harford, Joe B, Kim, Sang Soo, Pirollo, Kathleen F, Chang, Esther H

    Published in Viruses (31-03-2022)
    “…SGT-53 is a novel investigational agent that comprises an immunoliposome carrying a plasmid vector driving expression of the human gene that encodes wild-type…”
    Get full text
    Journal Article
  9. 9
  10. 10

    scL-2PAM: A Novel Countermeasure That Ameliorates Neuroinflammation and Neuronal Losses in Mice Exposed to an Anticholinesterase Organophosphate by Moghe, Manish, Kim, Sang-Soo, Guan, Miaoyin, Rait, Antonina, Pirollo, Kathleen F, Harford, Joe B, Chang, Esther H

    “…Due to their inhibition of acetylcholinesterase, organophosphates are among the most toxic of chemicals. Pralidoxime (a.k.a 2-PAM) is the only…”
    Get full text
    Journal Article
  11. 11

    Targeted Delivery of Small Interfering RNA : Approaching Effective Cancer Therapies by PIROLLO, Kathleen F, CHANG, Esther H

    Published in Cancer research (Chicago, Ill.) (01-03-2008)
    “…Three of the primary requirements for the development of effective dual-targeting therapeutic modalities for the treatment of cancer are the tumor-targeted…”
    Get full text
    Journal Article
  12. 12

    A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers by Siefker-Radtke, Arlene, Zhang, Xin-qiao, Guo, Charles C, Shen, Yu, Pirollo, Kathleen F, Sabir, Sharjeel, Leung, Chris, Leong-Wu, Cindy, Ling, Chi-Ming, Chang, Esther H, Millikan, Randall E, Benedict, William F

    Published in Molecular therapy (01-08-2016)
    “…Gene therapy development has been limited by our inability to target multifocal cancer with systemic delivery. We developed a systemically administered,…”
    Get full text
    Journal Article
  13. 13

    The Clinical Potential of Targeted Nanomedicine: Delivering to Cancer Stem-like Cells by Kim, Sang-Soo, Rait, Antonina, Rubab, Farwah, Rao, Abhi K, Kiritsy, Michael C, Pirollo, Kathleen F, Wang, Shangzi, Weiner, Louis M, Chang, Esther H

    Published in Molecular therapy (01-02-2014)
    “…Cancer stem-like cells (CSCs) have been implicated in recurrence and treatment resistance in many human cancers. Thus, a CSC-targeted drug delivery strategy to…”
    Get full text
    Journal Article
  14. 14

    Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system by PIROLLO, Kathleen F, RAIT, Antonina, QI ZHOU, SUNG HEE HWANG, DAGATA, John A, ZON, Gerald, HOGREFE, Richard I, PALCHIK, Guillermo, CHANG, Esther H

    Published in Cancer research (Chicago, Ill.) (01-04-2007)
    “…The field of small interfering RNA (siRNA) as potent sequence-selective inhibitors of transcription is rapidly developing. However, until now, low transfection…”
    Get full text
    Journal Article
  15. 15

    Nanotherapeutics for Gene Modulation that Prevents Apoptosis in the Brain and Fatal Neuroinflammation by Kim, Sang-Soo, Rait, Antonina, Garrido-Sanabria, Emilio R., Pirollo, Kathleen F., Harford, Joe B., Chang, Esther H.

    Published in Molecular therapy (03-01-2018)
    “…The failure of therapeutic agents to cross the blood-brain barrier (BBB) has been a major impediment in the treatment of neurological disorders and brain…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity by Kim, Sang-Soo, Doherty, Caroline, Moghe, Manish, Rait, Antonina, Pirollo, Kathleen F, Harford, Joe B, Chang, Esther H

    Published in Cancers (01-10-2022)
    “…Because lung cancer remains the most common and lethal of cancers, novel therapeutic approaches are urgently needed. RB94 is a truncated form of retinoblastoma…”
    Get full text
    Journal Article
  18. 18

    A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme by Kim, Sang-Soo, PhD, Rait, Antonina, PhD, Kim, Eric, BSc, Pirollo, Kathleen F., PhD, Chang, Esther H., PhD

    Published in Nanomedicine (01-02-2015)
    “…Abstract Development of temozolomide (TMZ) resistance contributes to the poor prognosis for glioblastoma multiforme (GBM) patients. It was previously…”
    Get full text
    Journal Article
  19. 19

    Does a targeting ligand influence nanoparticle tumor localization or uptake? by Pirollo, Kathleen F, Chang, Esther H

    Published in Trends in biotechnology (Regular ed.) (01-10-2008)
    “…Inclusion of a tumor-targeting molecule in nanosized delivery systems increases their in vivo efficacy. However, the biodistribution and pharmacokinetics of…”
    Get full text
    Journal Article
  20. 20

    Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo by Yang, Chengli, PhD, Rait, Antonina, PhD, Pirollo, Kathleen F., PhD, Dagata, John A., PhD, Farkas, Natalia, PhD, Chang, Esther H., PhD

    Published in Nanomedicine (01-12-2008)
    “…Abstract To circumvent the problem of reduction of the supermagnetic properties of superparamagnetic iron oxide (SPIO) nanoparticles after chemical…”
    Get full text
    Journal Article